Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mitigating Diabetic Ketoacidosis in People With T1D and Chronic Kidney Disease on an SGLT1&2 Inhibitor: Ketosis Risk Factor Determination and Incorporation Into an Enhanced Glucose Ketone Report

NCT07325201 is registered in ClinicalTrials.gov with HealthPartners Institute as lead sponsor.

NCT NCT07325201
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07325201 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mitigating Diabetic Ketoacidosis in People With T1D and Chronic Kidney Disease on an SGLT1&2 Inhibitor: Ketosis Risk Factor Determination and Incorporation Into an Enhanced Glucose Ketone Report
Lead sponsor
HealthPartners Institute
Phase
Phase 2
Overall status
Not yet recruiting
Start date
September 30, 2026
Completion date
February 28, 2030
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease, chronic kidney disease (ckd) with diabetes mellitus (dm), diabetic ketoacidosis, ketones, type 1 diabetes mellitus